WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2025)
Top diagnostic & research stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best diagnostic & research stocks to buy now. Learn More.

Industry: Diagnostics & Research
OverviewZen RatingPriceValueGrowthFinancialsMomentumSentimentForecastDividends
Due Diligence
B
Diagnostics & Research is Zen Rated B and is the 48th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
SHC
SOTERA HEALTH CO
$4.78BN/A0.00%N/AN/AN/AN/A
IDXX
IDEXX LABORATORIES INC
$55.54BN/A0.00%N/AN/AN/AN/A
TMO
THERMO FISHER SCIENTIFIC INC
$211.36B0.23%9.70%$0.4300$1.293%02026-01-15
DHR
DANAHER CORP
$157.25B0.43%25.20%$0.3200$0.968%22025-12-262026-01-30
ILMN
ILLUMINA INC
$19.80BN/A0.00%N/AN/AN/AN/A
NEOG
NEOGEN CORP
$1.54BN/A0.00%N/AN/AN/AN/A
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$9.65BN/A0.00%N/AN/AN/AN/A
A
AGILENT TECHNOLOGIES INC
$38.74B0.54%22.90%$0.2480$0.7412%02026-01-062026-01-28
IQV
IQVIA HOLDINGS INC
$37.64BN/A0.00%N/AN/AN/AN/A
LH
LABCORP HOLDINGS INC
$21.21B1.13%28.10%$0.7200$2.8826%0
PRE
PRENETICS GLOBAL LTD
$222.05MN/A0.00%N/AN/AN/AN/A
QGEN
QIAGEN NV
$9.84BN/A0.00%$1.2800N/AN/A0
BNR
BURNING ROCK BIOTECH LTD
$209.88MN/A0.00%N/AN/AN/AN/A
CDNA
CAREDX INC
$1.00BN/A0.00%N/AN/AN/AN/A
CAI
CARIS LIFE SCIENCES INC
$7.67BN/AN/AN/AN/AN/AN/A
FLGT
FULGENT GENETICS INC
$850.09MN/A0.00%N/AN/AN/AN/A
PRPO
PRECIPIO INC
$41.91MN/A0.00%N/AN/AN/AN/A
MEDP
MEDPACE HOLDINGS INC
$15.69BN/A0.00%N/AN/AN/AN/A
DGX
QUEST DIAGNOSTICS INC
$19.92B1.34%27.20%$0.8000$2.4031%02026-01-132026-01-28
FONR
FONAR CORP
$97.27MN/A0.00%N/AN/AN/AN/A
MYGN
MYRIAD GENETICS INC
$647.84MN/A0.00%N/AN/AN/AN/A
WAT
WATERS CORP
$22.45BN/A0.00%N/AN/AN/AN/A
MTD
METTLER TOLEDO INTERNATIONAL INC
$28.29BN/A0.00%N/AN/AN/AN/A
ACRS
ACLARIS THERAPEUTICS INC
$328.29MN/A0.00%N/AN/AN/AN/A
BLLN
BILLIONTOONE INC
$4.23BN/AN/AN/AN/AN/AN/A
NEO
NEOGENOMICS INC
$1.50BN/A0.00%N/AN/AN/AN/A
GH
GUARDANT HEALTH INC
$12.29BN/A0.00%N/AN/AN/AN/A
GRAL
GRAIL INC
$3.35BN/A0.00%N/AN/AN/AN/A
ICLR
ICON PLC
$13.69BN/A0.00%N/AN/AN/AN/A
XGN
EXAGEN INC
$145.27MN/A0.00%N/AN/AN/AN/A
CSTL
CASTLE BIOSCIENCES INC
$1.16BN/A0.00%N/AN/AN/AN/A
RDNT
RADNET INC
$5.50BN/A0.00%N/AN/AN/AN/A
RVTY
REVVITY INC
$10.97B0.22%14.10%$0.0700$0.213%02026-01-162026-02-06
BDSX
BIODESIX INC
$59.99MN/A0.00%N/AN/AN/AN/A
NTRA
NATERA INC
$31.12BN/A0.00%N/AN/AN/AN/A
OPK
OPKO HEALTH INC
$1.01BN/A0.00%N/AN/AN/AN/A
MDXH
MDXHEALTH SA
$15.54MN/A0.00%N/AN/AN/AN/A
TWST
TWIST BIOSCIENCE CORP
$1.96BN/A0.00%N/AN/AN/AN/A
NOTV
INOTIV INC
$21.62MN/A0.00%N/AN/AN/AN/A
IMDX
INSIGHT MOLECULAR DIAGNOSTICS INC
$136.44MN/A0.00%N/AN/AN/AN/A
PSNL
PERSONALIS INC
$687.35MN/A0.00%N/AN/AN/AN/A
STIM
NEURONETICS INC
$105.47MN/A0.00%N/AN/AN/AN/A
DRIO
DARIOHEALTH CORP
$81.56MN/A0.00%N/AN/AN/AN/A
NDRA
ENDRA LIFE SCIENCES INC
$5.76MN/A0.00%N/AN/AN/AN/A
LAB
STANDARD BIOTOOLS INC
$596.08MN/A0.00%N/AN/AN/AN/A
BIAF
BIOAFFINITY TECHNOLOGIES INC
$5.80MN/A0.00%N/AN/AN/AN/A
BNBX
BNB PLUS CORP
$2.84MN/A0.00%N/AN/AN/AN/A
VNRX
VOLITIONRX LTD
$32.79MN/A0.00%N/AN/AN/AN/A
XWEL
XWELL INC
$4.19MN/A0.00%N/AN/AN/AN/A
MBAI
CHECK-CAP LTD
$10.47MN/A0.00%N/AN/AN/AN/A
ADVB
ADVANCED BIOMED INC
$8.40MN/A0.00%N/AN/AN/AN/A
MYNZ
MAINZ BIOMED NV
$4.38MN/A0.00%N/AN/AN/AN/A
PRPH
PROPHASE LABS INC
$4.85MN/A0.00%$0.3000N/AN/A0
ISPC
ISPECIMEN INC
$3.79MN/A0.00%N/AN/AN/AN/A
EXAS
EXACT SCIENCES CORP
$19.25BN/A0.00%N/AN/AN/AN/A
TRIB
TRINITY BIOTECH PLC
$16.70MN/A0.00%N/AN/AN/AN/A
SERA
SERA PROGNOSTICS INC
$138.56MN/A0.00%N/AN/AN/AN/A
1

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best diagnostic & research stocks to buy right now are:

1. Sotera Health Co (NASDAQ:SHC)


Sotera Health Co (NASDAQ:SHC) is the #1 top diagnostic & research stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Sotera Health Co (NASDAQ:SHC) is: Value: C, Growth: A, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Sotera Health Co (NASDAQ:SHC) has a Due Diligence Score of 24, which is -2 points lower than the diagnostic & research industry average of 26. Although this number is below the industry average, our proven quant model rates SHC as a "A".

SHC passed 8 out of 33 due diligence checks and has weak fundamentals. Sotera Health Co has seen its stock return 28.52% over the past year, overperforming other diagnostic & research stocks by 16 percentage points.

Sotera Health Co has an average 1 year price target of $18.00, an upside of 7.08% from Sotera Health Co's current stock price of $16.81.

Sotera Health Co stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Sotera Health Co, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Idexx Laboratories (NASDAQ:IDXX)


Idexx Laboratories (NASDAQ:IDXX) is the #2 top diagnostic & research stock out of 57 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Idexx Laboratories (NASDAQ:IDXX) is: Value: C, Growth: C, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Idexx Laboratories (NASDAQ:IDXX) has a Due Diligence Score of 50, which is 24 points higher than the diagnostic & research industry average of 26.

IDXX passed 17 out of 33 due diligence checks and has strong fundamentals. Idexx Laboratories has seen its stock return 62.87% over the past year, overperforming other diagnostic & research stocks by 50 percentage points.

Idexx Laboratories has an average 1 year price target of $751.25, an upside of 8% from Idexx Laboratories's current stock price of $695.60.

Idexx Laboratories stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Idexx Laboratories, 62.5% have issued a Strong Buy rating, 12.5% have issued a Buy, 25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Thermo Fisher Scientific (NYSE:TMO)


Thermo Fisher Scientific (NYSE:TMO) is the #3 top diagnostic & research stock out of 57 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Thermo Fisher Scientific (NYSE:TMO) is: Value: B, Growth: C, Momentum: C, Sentiment: C, Safety: A, Financials: C, and AI: C.

Thermo Fisher Scientific (NYSE:TMO) has a Due Diligence Score of 42, which is 16 points higher than the diagnostic & research industry average of 26.

TMO passed 15 out of 38 due diligence checks and has strong fundamentals. Thermo Fisher Scientific has seen its stock return 6.38% over the past year, underperforming other diagnostic & research stocks by -6 percentage points.

Thermo Fisher Scientific has an average 1 year price target of $631.31, an upside of 12.22% from Thermo Fisher Scientific's current stock price of $562.56.

Thermo Fisher Scientific stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Thermo Fisher Scientific, 62.5% have issued a Strong Buy rating, 31.25% have issued a Buy, 6.25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the diagnostic & research stocks with highest dividends?

Out of 6 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 1.34%, which is 1 percentage points higher than the diagnostic & research industry average of 0.65%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 27.2% indicates that its dividend yield is sustainable for the long-term.

2. Labcorp Holdings (NYSE:LH)


Labcorp Holdings (NYSE:LH) has an annual dividend yield of 1.13%, which is the same as the diagnostic & research industry average of 0.65%. Labcorp Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Labcorp Holdings's dividend has not shown consistent growth over the last 10 years.

Labcorp Holdings's dividend payout ratio of 28.1% indicates that its dividend yield is sustainable for the long-term.

3. Agilent Technologies (NYSE:A)


Agilent Technologies (NYSE:A) has an annual dividend yield of 0.54%, which is the same as the diagnostic & research industry average of 0.65%. Agilent Technologies's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Agilent Technologies's dividend has shown consistent growth over the last 10 years.

Agilent Technologies's dividend payout ratio of 22.9% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks down?

Diagnostic & research stocks were down -0.4% in the last day, and down -2.23% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are down.

What are the most undervalued diagnostic & research stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued diagnostic & research stocks right now are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) is the most undervalued diagnostic & research stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Qiagen Nv has a valuation score of 29, which is 15 points higher than the diagnostic & research industry average of 14. It passed 2 out of 7 valuation due diligence checks.

Qiagen Nv's stock has dropped -0.29% in the past year. It has underperformed other stocks in the diagnostic & research industry by -13 percentage points.

2. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the second most undervalued diagnostic & research stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Fonar has a valuation score of 71, which is 57 points higher than the diagnostic & research industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has dropped -3.4% in the past year. It has underperformed other stocks in the diagnostic & research industry by -16 percentage points.

3. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the third most undervalued diagnostic & research stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Icon has a valuation score of 43, which is 29 points higher than the diagnostic & research industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Icon's stock has dropped -11.77% in the past year. It has underperformed other stocks in the diagnostic & research industry by -24 percentage points.

Are diagnostic & research stocks a good buy now?

53.49% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 8.62% over the next year.

2.13% of diagnostic & research stocks have a Zen Rating of A (Strong Buy), 29.79% of diagnostic & research stocks are rated B (Buy), 59.57% are rated C (Hold), 4.26% are rated D (Sell), and 4.26% are rated F (Strong Sell).

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 22.29x.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.